Top Research Reports for Amazon, Boston Scientific & Shopify

16.08.24 21:01 Uhr

Werte in diesem Artikel
Aktien

166,18 EUR -3,48 EUR -2,05%

76,00 EUR -0,50 EUR -0,65%

Indizes

PKT PKT

42.215,9 PKT -136,8 PKT -0,32%

20.035,0 PKT 241,7 PKT 1,22%

18.137,9 PKT 219,4 PKT 1,22%

2.761,3 PKT -6,8 PKT -0,25%

5.733,7 PKT -17,4 PKT -0,30%

Friday, August 16, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Boston Scientific Corporation (BSX) and Shopify Inc. (SHOP), as well as a micro-cap stock, Cooper-Standard Holdings Inc. (CPS). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Amazon shares have outperformed the Zacks Internet - Commerce industry over the past year (+32.6% vs. +22.5%). The Zacks analyst believes that strengthening AWS services portfolio and its growing adoption rate, ultrafast delivery services and expanding content portfolio have aided Amazon’s growth. The company’s expanding global presence remains a positive. Growing capabilities in grocery, pharmacy, healthcare and autonomous driving are other positives.Yet, macroeconomic challenges and foreign exchange headwinds remain concerns.(You can read the full research report on Amazon here >>>)Boston Scientific shares have outperformed the Zacks Medical - Products industry over the past year (+52.3% vs. +10.1%). The Zacks analyst believes that strong worldwide demand for the company’s electrophysiology and structural heart lines, traction in the United States and outside for its the next generation WATCHMAN FLX and FLX Pro, as well as contribution from accretive acquisitions have remained important drivers of growth.However, mounting costs due to worldwide geopolitical issues are major concerns. FX headwinds continue to largely offset the company’s performance.(You can read the full research report on Boston Scientific here >>>)Shares of Shopify have outperformed the Zacks Internet - Services industry over the last two years (+100.6% vs. +34.5%). Per the Zacks analyst, strong adoption of new merchant-friendly solutions like Bill Pay, Tax Platform and Collective holds promise for Shopify’s prospects. Expansion of back-office merchant solutions to more countries is also strengthening Shopify’s international footprint.Yet, raging inflation and cautious consumer spending remain headwinds.(You can read the full research report on Shopify here >>>)Cooper-Standard’s shares have outperformed the Zacks Automotive – Original Equipment industry over the last six months (-4.4% vs. -15.4%). The Zacks analyst believes that cost savings, lean initiatives and a structural shift to a product-line management have aided the company.However, the company faces challenges like declining operational cash flow, high debt leverage, and exposure to foreign exchange and commodity price risks.(You can read the full research report on Cooper-Standard here >>>)Other noteworthy reports we are featuring today include TotalEnergies SE (TTE), Cadence Design Systems, Inc. (CDNS) and General Motors Company (GM).Director of ResearchSheraz MianNote: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports.Today's Must ReadPrime Momentum & Growing AWS Adoption Benefit Amazon (AMZN)Boston Scientific (BSX) Thrives on EP Gains, Buyout StrengthProduct Rollouts & Growing Merchant Base Aid Shopify (SHOP)Featured ReportsMirum's (MIRM) Livmarli Aids Sales but Overdependence ConcernsPer the Zacks analyst, Mirum's lead drug, Livmarli is driving the top line. The recent label expansion of the drug should drive sales further. However, overdependence on Livmarli for revenues is a woeLoan & Deposit Growth Aid Fifth Third (FITB), High Costs AilPer the Zacks analyst, a rise in deposit and loan balances is likely to aid Fifth Third's top-line growth, while a high-cost base due to technological upgrades and branch expansion is a woe.Cadence (CDNS) Rides on Robust Portfolio & Buyout StrategiesPer the Zacks analyst, Cadence's performance is being driven by demand for the company's differentiated product portfolio. Synergies stemming from acquisitions bode well.Marathon (MRO) to Gain from ConocoPhillips DealThe Zacks analyst believes that Marathon Oil's proposed acquisition by ConocoPhillips will lead to significant synergies and help it become part of a larger, financially robust entity.Expanding LNG & Clean Energy Assets Aid TotalEnergies (TTE)Per the Zacks analyst TotalEnergies' presence in entire LNG value chain and expansion of clean energy generation through joint venture and acquisition will boost its performance.Under Armour (UAA) Gains on Strategic Brand TransformationPer the Zacks analyst, Under Armour is progressing in its multi-year transformation to strengthen its brand through deeper customer engagement, effective innovations and disciplined market strategy.Investments, Customer Growth Aid Essential Utilities (WTRG)Per the Zacks analyst, Essential Utilities' (WTRG) $7.2 billion investment to fortify it water and natural gas infrastructure and demand from expanding customer base are going to boost its performanceNew UpgradesStrong US Demand & Cost Cut Efforts to Aid General Motors (GM)General Motors' strong U.S. demand for pickups and SUVs should boost deliveries. The Zacks analyst is also optimistic about the firm's $2 billion cost reduction program by 2024 end.Wabtec (WAB) Benefits From Segmental Strength & DividendsPer the Zacks Analyst, Wabtec's top line is benefiting from higher sales across its Freight and Transit segments. Shareholder-friendly initiatives boost positively impact the company's bottom line.Pediatrix Medical's (MD) Strategic Buyouts, Telehealth AidPer the Zacks analyst, Pediatrix Medical's strategic acquisitions boost its footprint and service offerings across markets. Also, its expanding telehealth services will continue driving profits.New DowngradesWeak Demand, Turnaround Costs Ail Dow (DOW)Per the Zacks analyst, plant turnaround costs will exert pressure on the company's margins. It also faces headwinds from weaker demand in Europe due to lower consumer spending.Lower ASP Impedes Align Technology's (ALGN) GrowthThe Zacks analyst worries about Align technology's lower Invisalign ASP caused by higher discounts, unfavorable product mix shifts, and an unfavorable impact of a price adjustment in the U.K.Softness in Composites & Roofing Hurt Owens Corning (OC)Per the Zacks analyst, lower contribution from both Composites and Roofing segment and minimal growth in the Insulation business hurt Owens Corning.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.0% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amazon.com, Inc. (AMZN): Free Stock Analysis Report Boston Scientific Corporation (BSX): Free Stock Analysis Report General Motors Company (GM): Free Stock Analysis Report Cadence Design Systems, Inc. (CDNS): Free Stock Analysis Report Shopify Inc. (SHOP): Free Stock Analysis Report TotalEnergies SE Sponsored ADR (TTE): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Amazon

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Amazon

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Amazon

Analysen zu Amazon

DatumRatingAnalyst
03.09.2024Amazon BuyJefferies & Company Inc.
28.08.2024Amazon OutperformBernstein Research
02.08.2024Amazon BuyUBS AG
02.08.2024Amazon BuyGoldman Sachs Group Inc.
02.08.2024Amazon KaufenDZ BANK
DatumRatingAnalyst
03.09.2024Amazon BuyJefferies & Company Inc.
28.08.2024Amazon OutperformBernstein Research
02.08.2024Amazon BuyUBS AG
02.08.2024Amazon BuyGoldman Sachs Group Inc.
02.08.2024Amazon KaufenDZ BANK
DatumRatingAnalyst
26.09.2018Amazon HoldMorningstar
30.07.2018Amazon neutralJMP Securities LLC
13.06.2018Amazon HoldMorningstar
02.05.2018Amazon HoldMorningstar
02.02.2018Amazon neutralJMP Securities LLC
DatumRatingAnalyst
11.04.2017Whole Foods Market SellStandpoint Research
23.03.2017Whole Foods Market SellUBS AG
14.08.2015Whole Foods Market SellPivotal Research Group
04.02.2009Amazon.com sellStanford Financial Group, Inc.
26.11.2008Amazon.com ErsteinschätzungStanford Financial Group, Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Amazon nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"